Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Gilead Sciences
Work at Gilead Sciences?
Add yourself to this profile
2933
Gilead Sciences
Official Twitter feed for news and updates from Gilead Sciences. Gilead's Twitter guidelines can be found here on our site
Edit Profile
gilead.com
Technology
>
Biotechnology
B2b
Founded in
1987
More info
Elsewhere
Companies in the same industry
AgeneBio
Bioheart
Entelos
Morphogen-IX
LAM Therapeutics
Emerus Hospital Partners
GLO Science
InSite Vision
Molplex
Laurantis Pharma
Alexa global traffic share
Twitter followers
Overview
Acquisitions
1
Apps
2
Add info
Employees
Team size
5000+
Locations
HQ
United States
Headquarters
The Motley Fool
3 Biotech Stocks to Buy Now for the Long Haul
The Motley Fool
Can Gilead Sciences Rebound in the Second Half of 2016?
The Motley Fool
Can These Upstarts Knock Gilead Sciences Off Its Perch?
The Motley Fool
Gilead Sciences: Where's the Value?
The Motley Fool
The 3 Best Dividend Stocks for Beginning Investors
The Motley Fool
3 Biotech Stocks to Buy If the Market Crashes
The Motley Fool
3 Cheap Biotech Stocks You Can Buy Now
The Motley Fool
Better Buy: Gilead Sciences Inc. vs. Johnson & Johnson
The Motley Fool
3 Stocks the Market Loves to Hate, but You Should Love
The Motley Fool
Billionaires Are Bailing on Gilead Sciences -- Should You, Too?
The Motley Fool
Your 2016 Guide to Investing in Gilead Sciences Stock
The Motley Fool
Billionaire George Soros' Fund Bought These Stocks: Should You?
Stock markets
The Motley Fool
Do Sluggish Sales of Harvoni Make Gilead Sciences a
Health
Earnings
The Motley Fool
Gilead Sciences Thinks Its Own Stock Is a Biotech Bargain
Stock markets
The Motley Fool
3 Growth Dividend Stocks to Buy in May
Stock markets
Earnings
The Motley Fool
Digging Into Disappointment: What Investors Need To Know About Sarepta and Gilead Sciences'
Health
Stock markets
The Motley Fool
Breaking Down Gilead Sciences' Rough Quarter
Stock markets
Earnings
The Motley Fool
Better Buy: Gilead Sciences vs. Biogen
Stock markets
Health
Earnings
The Motley Fool
3 Dirt-Cheap Biotech Stocks To Buy
The Motley Fool
Gilead Sciences Is Cannibalizing Its Own Sales, and Management Loves It
AgeneBio
Bioheart
Entelos
LAM Therapeutics
Molplex
Laurantis Pharma